Envista Holdings Corporation (NVST) – What Are Researchers Thinking About This Stock?

Shares of Envista Holdings Corporation (NYSE:NVST) have been assigned an average rating of “Hold” from the seventeen brokerages that are covering the company, Marketbeat reports. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $29.00.

A number of equities analysts recently weighed in on NVST shares. Piper Sandler reduced their price target on Envista from $28.00 to $26.00 and set a “neutral” rating for the company in a report on Friday, October 9th. UBS Group upped their target price on Envista from $27.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, November 5th. Deutsche Bank Aktiengesellschaft set a $32.00 target price on Envista in a research report on Thursday, September 3rd. BMO Capital Markets cut their price target on shares of Envista from $29.00 to $26.00 and set a “market perform” rating for the company in a report on Monday, September 28th. Finally, Robert W. Baird lowered shares of Envista from an “outperform” rating to a “neutral” rating and dropped their target price for the company from $34.00 to $26.00 in a research report on Thursday, October 15th.

Envista Trading Up 3.2%

Shares of Envista stock opened at $25.98 on Thursday. The firm has a 50-day simple moving average of $24.36 and a two-hundred day simple moving average of $25.75. The company has a market cap of $4.17 billion, a P/E ratio of 6.71, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94. Envista has a fifty-two week low of $18.77 and a fifty-two week high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, November 4th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Envista had a return on equity of 8.26% and a net margin of 22.01%. The firm had revenue of $691.50 million for the quarter, compared to analysts’ expectations of $688.74 million. During the same period last year, the firm earned $0.32 EPS. The company’s quarterly revenue was up 3.2% on a year-over-year basis. As a group, equities analysts predict that Envista will post 1.56 earnings per share for the current fiscal year.

Insider Buying and Selling at Envista

In related news, SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. This trade represents a 22.65% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Envista

Several large investors have recently bought and sold shares of NVST. Arrowstreet Capital Limited Partnership lifted its position in shares of Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after acquiring an additional 2,210,847 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Envista by 2,662.1% during the second quarter. Wellington Management Group LLP now owns 1,686,415 shares of the company’s stock worth $44,437,000 after purchasing an additional 1,625,360 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Envista in the 2nd quarter valued at $37,316,000. Pzena Investment Management LLC acquired a new position in Envista in the 2nd quarter valued at $30,494,000. Finally, Renaissance Technologies LLC raised its stake in Envista by 195.9% in the 1st quarter. Renaissance Technologies LLC now owns 1,208,165 shares of the company’s stock valued at $30,651,000 after purchasing an additional 799,900 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation is a dental products and technology company that develops and supplies tools and services for dental professionals. Its offerings span implant dentistry, orthodontics, digital imaging, restorative care and other clinical applications.

The company’s products include dental implants and related treatment systems, orthodontic brackets and clear aligners, imaging equipment and software, and restorative and endodontic materials. Its brands include Nobel Biocare, Ormco, DEXIS, Kerr and KaVo.

Envista was formed in 2019 through the separation of Danaher Corporation’s dental businesses.